Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

TOTAL RENAL CARE INC

NPI: 1902869035 · INGLEWOOD, CA 90304 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more

$22.54M
Total Medicaid Paid
157,758
Total Claims
35,929
Beneficiaries
26
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialWINSTEL, JOHN (CHIEF ACCOUNTING OFFICER)
NPI Enumeration Date04/10/2006

Related Entities

Other providers sharing the same authorized official: WINSTEL, JOHN

ProviderCityStateTotal Paid
TOTAL RENAL CARE INC MIAMI FL $16.77M
DVA HEALTHCARE RENAL CARE INC LOS ANGELES CA $14.01M
DVA HEALTHCARE RENAL CARE INC BURBANK CA $10.72M
DVA HEALTHCARE RENAL CARE INC OAKLAND CA $10.67M
DVA HEALTHCARE RENAL CARE INC WESTMINSTER CA $8.32M
DVA HEALTHCARE RENAL CARE INC APPLE VALLEY CA $6.93M
DVA HEALTHCARE RENAL CARE INC GLENDALE CA $5.32M
RENAL TREATMENT CENTERS CALIFORNIA INC SANTA ANA CA $5.08M
DVA HEALTHCARE RENAL CARE INC BERKELEY CA $4.25M
TOTAL RENAL CARE INC PLANTATION FL $4.08M
DVA RENAL HEALTHCARE INC LOS ANGELES CA $4.01M
DVA HEALTHCARE OF MASSACHUSETTS INC SALEM MA $3.57M
DVA RENAL HEALTHCARE INC SIERRA VISTA AZ $3.52M
RENAL TREATMENT CENTERS-SOUTHEAST, LP. PANAMA CITY FL $3.14M
WESTON DIALYSIS CENTER LLC WESTON FL $3.01M
BEVERLY HILLS DIALYSIS PARTNERSHIP BEVERLY HILLS CA $2.90M
RENAL TREATMENT CENTERS CALIFORNIA INC EL MONTE CA $2.82M
TOTAL RENAL CARE INC ANTIOCH CA $2.72M
DVA HEALTHCARE RENAL CARE INC PHILADELPHIA PA $2.30M
DVA HEALTHCARE RENAL CARE INC FT LAUDERDALE FL $2.13M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 24,455 $5.29M
2019 14,937 $1.51M
2020 22,801 $2.83M
2021 32,511 $3.09M
2022 20,860 $3.20M
2023 21,727 $3.63M
2024 20,467 $2.98M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
90999 Unlisted dialysis procedure, inpatient or outpatient 81,262 8,529 $15.10M
0821 6,902 1,812 $6.68M
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) 20,058 2,992 $436K
J1270 Injection, doxercalciferol, 1 mcg 11,694 1,992 $152K
J1756 Injection, iron sucrose, 1 mg 8,760 3,429 $74K
A4657 Syringe, with or without needle, each 7,652 3,183 $30K
J0887 Injection, epoetin beta, 1 microgram, (for esrd on dialysis) 1,863 1,155 $18K
0250 5,576 454 $13K
J0604 Cinacalcet, oral, 1 mg, (for esrd on dialysis) 129 105 $9K
83970 2,455 2,363 $8K
90747 61 59 $5K
0302 675 565 $3K
82728 1,395 1,351 $2K
90662 101 98 $2K
90674 154 148 $2K
83550 1,189 1,140 $1K
83540 1,479 1,428 $896.95
85041 2,408 2,320 $778.60
85048 2,447 2,355 $671.85
J1200 Injection, diphenhydramine hcl, up to 50 mg 426 162 $257.97
G0008 Administration of influenza virus vaccine 30 27 $48.00
82108 133 129 $45.09
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 58 38 $20.84
87340 13 13 $11.40
J1644 Injection, heparin sodium, per 1000 units 825 69 $0.00
85045 13 13 $0.00